Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06306963

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGastric Emptying Breath Test13C-Spirulina GEBT (Cairn Diagnostics) is non-radioactive, non-invasive breath based test validated against scintigraphy for the measurement of gastric emptying. Patients will be mailed test kits to be done in their homes remotely along with telehealth assistance from the study team. After overnight fast and providing duplicate pre-meal breath samples, the patient consumes 27 grams of re-hydrated, precisely formulated, pasteurized scrambled egg mix containing a dose of 43 mg of 13C (provided by approximately 100 mg of 13C-Spirulina), 6 saltine crackers and 6 ounces (180 mL) of potable water. The caloric value of the meal is approximately 230 kCal.Patient will provide breath samples into provided glass tubes before and after test meal administration which are then mailed back to a central laboratory for analysis by gas isotope ratio mass spectrometry.

Timeline

Start date
2024-03-22
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2024-03-12
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06306963. Inclusion in this directory is not an endorsement.